A single centre study from western India to evaluate the frequency of developing second and subsequent multiple primary malignancies among cancer survivors

Author:

Sharma Anjali,Sharma Ajay,Patni Sanjeev,Gupta Anil,Ledwani Naresh,Saini Shashikant,Patni Nidhi,Bapna Ajay,Somani Naresh,Sharma Mudit,Verma Shubham,Sharma Gulshan Kumar,Nunia VandanaORCID

Abstract

Abstract Aim This study was designed to evaluate the frequency of developing second and subsequent primary cancers among cancer survivors. Methods We have retrospectively analyzed 121 multiple primary cancer patients treated at Bhagwan Mahavir Cancer Hospital and Research Centre, Jaipur, Rajasthan, India from the last 20 years. The survival analysis was performed by Kaplan-Meier methodology. Results The prevalence of multiple primary malignant tumors (MPMTs) was 1.51% (121/8000), with a male to female ratio of 1:1.42. In males most of the reported MPMTs were synchronous and most common first primary cancer cases were head & neck and lung whereas, in females most of the reported MPMTs were metachronous and most common first primary cancer cases were breast and gynaecological malignancies. Family history was reported in 15 cases. Maximum 33.05% patients received combined treatment of chemotherapy, radiotherapy and 91.73% (111/121) of patients with MPMTs were effectively followed up, 35 (28.92%) patients died and 5-year survival rate of the remaining 86 patients was 68.46%. Conclusions In the present observational study the most frequent sites of MPMTs in men were head & neck and lung whereas, in women breast and gynaecological sites were common. Therefore, careful monitoring and follow up are required for these patients.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference43 articles.

1. AIRTUM Working Group. Italian cancer figures, report 2013: Multiple tumours. Epidemiol Prev. 2013;37(4–5 Suppl 1):1–152 PMID: 24259384.

2. Angurana SL, Kapoor R, Kumar P, Khosla D, Kumar N, Sharma SC, et al. Quadruple malignancy in a single patient: a case report and comprehensive review of literature. J Cancer Res Ther. 2010;6:230–2. https://doi.org/10.4103/0973-1482.65237.

3. Bagri PK, Singh D, Singhal MK, Singh G, Mathur G, Jakhar SL, Beniwal S, Sharma N, Kumar HS, Sharma A, Bardia MR. Double primary malignancies: a clinical & pathological analysis report from a regional cancer institute in India. Iran J Cancer Prev. 2014;7(2):66–72 PMID: 25250152; PMCID: PMC4142942.

4. Băltătescu GI, Așchie M, Sârbu V. Synchronous ovarian dysgerminoma and breast carcinoma in a patient with positive immunostain of BRCA1. Chirurgia (Bucur). 2013;108(2):259–63 PMID: 23618579.

5. Bishen KA, Singh A. A case of dual malignancy: presenting the necessity for extensive sampling for pathologic examination. J Oral MaxillofacPathol. 2011;15:306–10. https://doi.org/10.4103/0973-029X.86698.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3